Common side effects include: Injection site reactions pain, redness, or swelling at the injection site Mild diarrhoea or gastrointestinal upset usually transient Skin reactions itching or rash (uncommon) Hypokalaemia rare, occurring when severe megaloblastic anaemia is corrected rapidly Serious adverse effects are extremely rare but may include anaphylaxis in hypersensitive individuals
Continued exposure to environmental toxins, unmanaged inflammation, or nutritional deficiencies can influence how long benefits are sustained
So these are also this lack of transparency and it's hard to get to the numbers, of course
In obesity trials, average losses ranged from around 15% on lower doses to nearly 21% on higher doses over 72 weeks
These doses are sub-therapeutic, meaning they fall below the level that clinical trials have demonstrated to produce statistically significant weight loss
Mazdutide is showing good results in current Phase III studies, and it might help reduce fat in the liver
